X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Procter & Gamble Health with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ACTAVIS (US) - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PROCTER & GAMBLE HEALTH   ACTAVIS
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
ACTAVIS
Dec-18
PROCTER & GAMBLE HEALTH/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs3,54913,773-   
Low Rs1,3019,239-   
Sales per share (Unadj.) Rs511.43,378.6-  
Earnings per share (Unadj.) Rs61.3-1,088.2-  
Cash flow per share (Unadj.) Rs74.0356.0-  
Dividends per share (Unadj.) Rs440.000-  
Dividend yield (eoy) %18.10-  
Book value per share (Unadj.) Rs927.813,935.1-  
Shares outstanding (eoy) m16.60332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.73.4 139.2%   
Avg P/E ratio x39.6-10.6 -374.2%  
P/CF ratio (eoy) x32.832.3 101.4%  
Price / Book Value ratio x2.60.8 316.6%  
Dividend payout %717.90-   
Avg Mkt Cap Rs m40,2573,826,978 1.1%   
No. of employees `0001.116.9 6.7%   
Total wages/salary Rs m1,3130-   
Avg. sales/employee Rs Th7,486.766,492.2 11.3%   
Avg. wages/employee Rs Th1,157.60-   
Avg. net profit/employee Rs Th897.2-21,417.2 -4.2%   
INCOME DATA
Net Sales Rs m8,4901,123,719 0.8%  
Other income Rs m24421,489 1.1%   
Total revenues Rs m8,7341,145,208 0.8%   
Gross profit Rs m1,48229,447 5.0%  
Depreciation Rs m211480,365 0.0%   
Interest Rs m064,845 0.0%   
Profit before tax Rs m1,514-494,274 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m66126,060 0.1%   
Tax Rs m563-6,264 -9.0%   
Profit after tax Rs m1,017-361,950 -0.3%  
Gross profit margin %17.52.6 666.0%  
Effective tax rate %37.11.3 2,931.1%   
Net profit margin %12.0-32.2 -37.2%  
BALANCE SHEET DATA
Current assets Rs m15,343460,891 3.3%   
Current liabilities Rs m1,960407,719 0.5%   
Net working cap to sales %157.64.7 3,331.4%  
Current ratio x7.81.1 692.4%  
Inventory Days Days4920 248.8%  
Debtors Days Days2866 42.9%  
Net fixed assets Rs m1,209127,199 1.0%   
Share capital Rs m1660-   
"Free" reserves Rs m15,2350-   
Net worth Rs m15,4014,634,815 0.3%   
Long term debt Rs m01,632,086 0.0%   
Total assets Rs m17,5957,245,270 0.2%  
Interest coverage xNM-6.6-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.50.2 311.1%   
Return on assets %5.8-4.1 -141.0%  
Return on equity %6.6-7.8 -84.6%  
Return on capital %10.3-4.8 -211.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-2,7320-   
CASH FLOW
From Operations Rs m-1,304401,462 -0.3%  
From Investments Rs m12,697220,551 5.8%  
From Financial Activity Rs m-301-689,030 0.0%  
Net Cashflow Rs m11,093-66,681 -16.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.18 Rs / USD

Compare PROCTER & GAMBLE HEALTH With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PROCTER & GAMBLE HEALTH With: CADILA HEALTHCARE  AJANTA PHARMA  SUN PHARMA  ALEMBIC PHARMA  FULFORD INDIA  



Today's Market

Dividend Stocks Amid Volatile Stock Markets; US-China Trade War and More(Podcast)

The market, which has been caught in the grip of the bears, gave a negative yearly return for first time in last eight years.

Related Views On News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

7 Stocks to Buy in Today's Difficult Market (The 5 Minute Wrapup)

Aug 5, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

The Perfect Stock in the Rebirth of India (The 5 Minute Wrapup)

Aug 8, 2019

This debt-free, well-managed company is all set to soar.

My Top 3 Dividend Millionaire Stocks (Profit Hunter)

Aug 7, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

This 60-Year Old Smallcap Company Could Be Our Next Recommendation (The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Qatar is Rearing Cows...this is Good News for India

Aug 9, 2019

Qatar has turned around after the Saudi embargo. This is good news for India.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Aug 16, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 8-QTR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS